This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Reconsidering Adult ADHD

Reconsidering Adult ADHD


Expert Perspective

Time to Complete

1.50 hours


September 1, 2015


September 1, 2016
Add to Queue

Maximum Credits

1.50 / AMA PRA Category 1 Credit(s)TM
1.50 / CE for Nurses (1.50 pharmacology credits)
1.50 / CE for Pharmacists (0.15 CEUs)
1.50 / CE for Case Managers
1.50 / CE for Social Workers

Accredited Provider

This educational initiative is provided by CME Outfitters.

Commercial Supporter

Supported by an independent medical educational grant from Shire

Program Description

Attention-deficit/hyperactivity disorder (ADHD) is a common neuropsychiatric disorder in adults in the United States, with a prevalence rate of 4.4%, making it second only to major depression. The National Comorbidity Survey Replication study revealed that only one in 10 adults identified as having ADHD were being treated for their ADHD, even though 45% had been in treatment for other mental health disorders during the previous year.1

Adult psychiatrists as well as many primary care providers are often not familiar with its presentation in childhood or adulthood. In addition, clinicians may be less familiar with how to obtain a good developmental history regarding the typical developmental abnormalities associated with the disorder since this is not typically done in an adult screening. Comorbid symptoms are common, and many of the associated symptoms of ADHD are easily understood within the framework of mood disorders with which adult psychiatrists are more familiar.

The educational content for this neuroscienceCME Live and On Demand webcast will be drawn from both the evidence and interviews with a panel of adult patients with ADHD to reflect the challenges faced in managing their disease. Faculty will use these insights to address key goals to better screen adult patients for ADHD and develop a comprehensive treatment strategy.


1. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723. PMID: 1658544.

Intended Audience

Physicians, physician assistants, nurse practitioners, nurses, pharmacists, social workers, case managers, and other health care professionals interested in adult ADHD

Educational Objectives

At the end of this CME/CE activity, participants should be able to:

  • Screen adult patients for a history of ADHD and evaluate for ADHD symptoms especially as comorbid with other disorders
  • Implement a comprehensive treatment strategy that is personalized with patient input and includes both pharmacological and nonpharmacological approaches to the management of adult ADHD

The following learning objectives pertain only to those requesting CE for Nurses credit:

  • Evaluate a screening plan for adult patients for a history of ADHD and evaluation of symptoms
  • Review a comprehensive treatment strategy that is personalized with patient input and includes both pharmacological and non-pharmacological approaches to the management of adult ADHD

Conflict Of Interest Disclosure Policy

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.


Timothy E. Wilens, MD
Chief, Division of Child and Adolescent Psychiatry
Co-Director, Center for Addiction Medicine
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard Medical School
Boston, MA

Dr. Wilens has disclosed that he has received research grants from the National Institue on Drub Abuse. He serves as a consultant to Euthymics Bioscience/Neurovance; Ironshore Pharmaceuticals & Development, Inc.; (NIDA/NIH) National Institute on Drug Abuse; Sunovion Pharmaceuticals Inc.; and Tris Pharma Inc.

Doris M. Greenberg, MD
Associate Clinical Professor of Pediatrics
Mercer University School of Medicine
Attending Pediatrician
Memorial University Medical Center Children's Hospital
Savannah, GA

Dr. Greenberg has disclosed that she is a stock shareholder (directly purchased) in Abbott; AbbVie Inc.; GlaxoSmithKline; Johnson & Johnson; Novartis; and Novo Nordisk.

Adelaide Sherwood Robb, MD
Chief, Division of Psychology and Behavioral Health
Director, Psychiatry Research
Center for Translational Science
Children's National Health Center
Professor, Psychiatry and Pediatrics
The George Washington University School of Medicine and Health Sciences
Washington, DC

Dr. Robb has disclosed that she has received research grants from Forest Laboratories, LLC; Lundbeck; National Institute of Neurological Disorders and Stroke (NINDS); Pfizer Inc.; Sunovion Pharmaceuticals Inc.; and SyneuRx. She serves as a consultant to Actavis Inc.; Ironshore Pharmaceuticals & Development, Inc.; Lundbeck; and Takeda Pharmaceuticals U.S.A., Inc. She is a stock shareholder (directly purchased) in IRA since 2001-2003 Eli Lilly and Company; GlaxoSmithKline ; Pfizer Inc.; and Johnson & Johnson. She has other financial or material support from Neuronetics on DSMB.

Accredited Provider Disclosure

The CME Outfitters, LLC staff has nothing to disclose.

Publishing Staff Disclosures

Tony Graham, MD (peer reviewer) has no disclosures to report.
Kimberley Murray, RN, MS (peer reviewer) has no disclosures to report.
Robert Kennedy (planning committee) has no disclosures to report.
Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

CME Outfitters designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.




CE for Nurses

Accreditation Statement

Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.50 contact hours.

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.50 contact hours of pharmacotherapeutic contact hours.




CE for Pharmacists

Accreditation Statement

CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.50 contact hours (0.15 CEUs)

Universal Activity Number: 0376-0000-15-022-H01-P

Activity Type: knowledge-based




CE for Social Workers

Accreditation Statement

This Program is approved by the National Association of Social Workers (Approval # 886407722-3048) for 1.50 continuing education contact hours.




CE for Case Managers

Accreditation Statement

This program has been approved for 1.50 CE contact hours by The Commission for Case Manager Certification (CCMC). Activity Code: I00016636, Approval #: 150002559

Disclosure of Unlabeled Use

CME Outfitters, LLC, the faculty, and Shire do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


There are no fees for participating in this CME/CE activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section.

To obtain a certificate, participants must receive a score of 75% or better on the posttest. The post-test can be accessed at the end of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact

If you have any other questions relating to your certificate or other issues with this activity, please contact


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue